Farnaz Nowroozi

912 total citations
7 papers, 711 citations indexed

About

Farnaz Nowroozi is a scholar working on Molecular Biology, Pharmacology and Infectious Diseases. According to data from OpenAlex, Farnaz Nowroozi has authored 7 papers receiving a total of 711 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Pharmacology and 0 papers in Infectious Diseases. Recurrent topics in Farnaz Nowroozi's work include Plant biochemistry and biosynthesis (6 papers), Microbial Metabolic Engineering and Bioproduction (6 papers) and Microbial Natural Products and Biosynthesis (5 papers). Farnaz Nowroozi is often cited by papers focused on Plant biochemistry and biosynthesis (6 papers), Microbial Metabolic Engineering and Bioproduction (6 papers) and Microbial Natural Products and Biosynthesis (5 papers). Farnaz Nowroozi collaborates with scholars based in United States. Farnaz Nowroozi's co-authors include Jay D. Keasling, Jack D. Newman, Larry C. Anthony, Gina Kwon, Jennifer R. Anthony, Jessica Marshall, Michelle C. Y. Chang, Karyn L. Newman, Douglas J. Pitera and Simon Ermakov and has published in prestigious journals such as Applied Microbiology and Biotechnology, Phytochemistry and Biotechnology and Bioengineering.

In The Last Decade

Farnaz Nowroozi

6 papers receiving 688 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Farnaz Nowroozi United States 6 685 217 89 66 51 7 711
Andrew E. Owens United States 7 755 1.1× 178 0.8× 90 1.0× 74 1.1× 52 1.0× 8 792
Tizita Horning United States 4 834 1.2× 275 1.3× 117 1.3× 108 1.6× 78 1.5× 4 883
Hiroko Tsuruta United States 8 920 1.3× 373 1.7× 127 1.4× 132 2.0× 89 1.7× 11 1.0k
Siavash Partow Sweden 8 805 1.2× 140 0.6× 187 2.1× 164 2.5× 27 0.5× 9 875
Fuyuan Jing United States 9 471 0.7× 75 0.3× 69 0.8× 68 1.0× 93 1.8× 12 540
Kasper Møller Denmark 12 585 0.9× 94 0.4× 95 1.1× 86 1.3× 14 0.3× 16 669
Shaoxin Chen China 14 410 0.6× 195 0.9× 40 0.4× 77 1.2× 38 0.7× 43 533
Sang‐Ki Rhee South Korea 14 282 0.4× 38 0.2× 55 0.6× 137 2.1× 23 0.5× 31 486
Masayoshi Muramatsu Japan 12 359 0.5× 78 0.4× 40 0.4× 82 1.2× 20 0.4× 22 454
Ahmed A. Shindia Egypt 14 204 0.3× 166 0.8× 24 0.3× 126 1.9× 20 0.4× 27 466

Countries citing papers authored by Farnaz Nowroozi

Since Specialization
Citations

This map shows the geographic impact of Farnaz Nowroozi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Farnaz Nowroozi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Farnaz Nowroozi more than expected).

Fields of papers citing papers by Farnaz Nowroozi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Farnaz Nowroozi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Farnaz Nowroozi. The network helps show where Farnaz Nowroozi may publish in the future.

Co-authorship network of co-authors of Farnaz Nowroozi

This figure shows the co-authorship network connecting the top 25 collaborators of Farnaz Nowroozi. A scholar is included among the top collaborators of Farnaz Nowroozi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Farnaz Nowroozi. Farnaz Nowroozi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Nowroozi, Farnaz, Edward E. K. Baidoo, Simon Ermakov, et al.. (2013). Metabolic pathway optimization using ribosome binding site variants and combinatorial gene assembly. Applied Microbiology and Biotechnology. 98(4). 1567–1581. 82 indexed citations
2.
Kirby, James, Sydnor T. Withers, Farnaz Nowroozi, et al.. (2010). Cloning of casbene and neocembrene synthases from Euphorbiaceae plants and expression in Saccharomyces cerevisiae. Phytochemistry. 71(13). 1466–1473. 77 indexed citations
3.
Nowroozi, Farnaz. (2010). Construction and Optimization of Mevalonate Pathway for Production of Isoprenoids in Escherichia coli. eScholarship (California Digital Library).
4.
Anthony, Jennifer R., Larry C. Anthony, Farnaz Nowroozi, et al.. (2008). Optimization of the mevalonate-based isoprenoid biosynthetic pathway in Escherichia coli for production of the anti-malarial drug precursor amorpha-4,11-diene. Metabolic Engineering. 11(1). 13–19. 237 indexed citations
5.
Yoshikuni, Yasuo, Jeffrey A. Dietrich, Farnaz Nowroozi, Patricia C. Babbitt, & Jay D. Keasling. (2008). Redesigning Enzymes Based on Adaptive Evolution for Optimal Function in Synthetic Metabolic Pathways. Europe PMC (PubMed Central). 15(6). 607–618. 43 indexed citations
6.
Suthers, Patrick F., Anthony P. Burgard, Madhukar S. Dasika, et al.. (2007). Metabolic flux elucidation for large-scale models using 13C labeled isotopes. Metabolic Engineering. 9(5-6). 387–405. 86 indexed citations
7.
Newman, Jack D., Jessica Marshall, Michelle C. Y. Chang, et al.. (2006). High‐level production of amorpha‐4,11‐diene in a two‐phase partitioning bioreactor of metabolically engineered Escherichia coli. Biotechnology and Bioengineering. 95(4). 684–691. 186 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026